Literature DB >> 23728208

Non-cystic fibrosis bronchiectasis.

M J McDonnell1, C Ward, J L Lordan, R M Rutherford.   

Abstract

Bronchiectasis is a chronic debilitating condition with considerable phenotypic diversity. A vicious cycle of infection and inflammation exists in damaged airways with patients suffering from persistent cough, purulent sputum production, recurrent chest infections and general malaise. The associated burden of disease in terms of increased morbidity, reduced quality of life and the socioeconomic cost of long-term management is significant. Further research is essential to improve our understanding of the development and progression of this disease. This article reviews what is currently known about bronchiectasis, its pathophysiology, aetiology and management strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728208     DOI: 10.1093/qjmed/hct109

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  9 in total

1.  Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.

Authors:  Li-Chao Fan; Hai-Wen Lu; Ping Wei; Xiao-Bin Ji; Shuo Liang; Jin-Fu Xu
Journal:  BMC Infect Dis       Date:  2015-03-27       Impact factor: 3.090

Review 2.  The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects.

Authors:  Kelly S Brower; Michael T Del Vecchio; Stephen C Aronoff
Journal:  BMC Pediatr       Date:  2014-12-10       Impact factor: 2.125

3.  Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis.

Authors:  Hriday De; Syed Md Azad; Prabhas P Giri; Priyankar Pal; Apurba Ghosh; Anirban Maitra
Journal:  Respir Med Case Rep       Date:  2016-12-19

4.  Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013.

Authors:  Derek Weycker; Gary L Hansen; Frederic D Seifer
Journal:  Chron Respir Dis       Date:  2017-05-30       Impact factor: 2.444

5.  Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.

Authors:  Donghai Wang; Wenlong Fu; Jihong Dai
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 6.  '"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection.

Authors:  M Alexandra Lake; Lyn R Ambrose; Marc C I Lipman; David M Lowe
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

7.  Bacterial colonization and associated factors in patients with bronchiectasis.

Authors:  Sermin Borekci; Ayse Nigar Halis; Gokhan Aygun; Benan Musellim
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219

Review 8.  The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.

Authors:  Ulrich Baumann; John M Routes; Pere Soler-Palacín; Stephen Jolles
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

9.  Poor outcomes in recurrent tuberculosis: More than just drug resistance?

Authors:  Danielle B Cohen; Geriant Davies; Wakisa Malwafu; Helen Mangochi; Elizabeth Joekes; Simon Greenwood; Liz Corbett; S Bertel Squire
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.